These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35966252)

  • 1. Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors.
    Xiao D; Song J
    Comput Math Methods Med; 2022; 2022():9190292. PubMed ID: 35966252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diabetes on the prognosis, serum inflammatory factors, and quality of life of patients with lower extremity arteriosclerosis obliterans after vascular intervention: a retrospective comparative cohort study.
    Zhao H; Zhuo T; Hao X; Fan X; Zhao P
    Ann Palliat Med; 2022 Aug; 11(8):2720-2729. PubMed ID: 36064362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis.
    Yang B; Xiaping Z
    Front Surg; 2022; 9():1031108. PubMed ID: 36704514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alprostadil plus cilostazol on the treatment outcomes and inflammatory factors in patients with lower extremity arteriosclerosis obliterans receiving evidence-based care.
    Liang H; Liu P; Yang M; Di P; Wu W; Li H; Liu Y
    Clin Hemorheol Microcirc; 2024; 87(4):405-413. PubMed ID: 38848169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans.
    Sun J; Deng Q; Wang J; Duan S; Chen H; Zhou H; Zhou Z; Yu F; Guo F; Liu C; Xu S; Song L; Wang Y; Feng H; Yu L
    Front Cardiovasc Med; 2022; 9():853583. PubMed ID: 35445093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression level and clinical significance of LncRNA PVT1 in the serum of patients with LEASO.
    Su X; Yuan X; Li F; Yang G; Du L; Zhao F; Zhao R; Ou M
    PeerJ; 2023; 11():e16057. PubMed ID: 37744231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydration therapy and nursing intervention on preventing contrast-induced nephropathy after interventional treatment of lower extremity arteriosclerosis obliterans.
    Chen J; Zhang X; Wu W; Yuan Y; Xue W; Cao W; Du R
    Technol Health Care; 2024; 32(3):1361-1369. PubMed ID: 38073340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients.
    Li H; Gui H; Yuan G; Zheng X; Gao C; Yuan H
    Scand J Clin Lab Invest; 2018 Jul; 78(4):269-274. PubMed ID: 29553861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Multidimensional Nursing Intervention for Pain on Pain Levels in Patients with Lower Extremity Arteriosclerosis Obliterans.
    Yang M; Zhao S; He Y
    Altern Ther Health Med; 2022 Jul; 28(5):38-43. PubMed ID: 35648692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of drug-coated balloon and common balloon for treatment of superficial femoral artery and popliteal artery arteriosclerosis obliterans: prospective randomized controlled triac].
    Lu JY; Gu JP; Xu WJ; Lou WS; Wang T
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):296-300. PubMed ID: 28377342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the clinical efficacy of endovascular reconstruction versus bypass surgery for transatlantic inter-society consensus II C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans].
    Zhuang JM; Li X; Li TR; Dong GX; Zhao J; Luan JY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):957-61. PubMed ID: 26679657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma heparin cofactor II activity correlates with the incidence of in-stent restenosis after the intervention of arteriosclerosis obliterans in lower extremity].
    Lu H; Guo P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 40(2):177-81. PubMed ID: 25769326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal therapy treatment in thromboangiitis obliterans: a retrospective clinical study.
    Li G; Zefr C; Yang B; He C; Hafner F; Pang H
    Ann Palliat Med; 2020 Jul; 9(4):1696-1707. PubMed ID: 32692190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized controlled trial to superficial femoral artery recanalization for lower extremity arteriosclerosis obliterans].
    Zhuang JM; Li X; Li TR; Zhao J; Luan JY; Wang CM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 49(1):153-7. PubMed ID: 28203023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical efficacy and outcome of endovascular therapy for complex arteriosclerosis obliterans of the lower extremities].
    Wei W; Dong H; Jiang X; Peng M; Li B; Zou Y; Guan T; Zhang H; Wu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):831-4. PubMed ID: 25547446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans.
    Lian W; Nie H; Yuan Y; Wang K; Chen W; Ding L
    J Invest Surg; 2021 Jul; 34(7):765-770. PubMed ID: 31996054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety Differences between Domestic Paclitaxel Drug-Coated Balloons and Metal Bare Stents in the Treatment of ASO of Femoral-Popliteal Arteries Type IIA-C.
    Wei F; Huang F; Cui F
    Contrast Media Mol Imaging; 2022; 2022():6817838. PubMed ID: 35854777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Level of Tim-3
    Cui L; Chen L; Dai Y; Ou J; Qiu M; Wang S
    Front Immunol; 2022; 13():871362. PubMed ID: 35757718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
    Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
    Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Immune-Inflammation Index Predicts Restenosis after Interventions for Lower Extremity Arteriosclerosis Obliterans.
    Tian SY
    Heart Surg Forum; 2023 May; 26(3):E225-E233. PubMed ID: 37401437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.